The DOI matches its Crossref record; 291 of the 291 references it cites were found in a registry or an index.
Oral Anticoagulant Therapy
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Hematological Problems in Pediatric Intensive Care
Revel-Vilk, S., Cox, P., Robitaille, N., & Blanchette, V. (2014) · Pediatric and Adolescent Medicine · doi:10.1159/000350346 · Cited by 3,508
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007903 · Cited by 3,237
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
Schulman, S., Kearon, C., Kakkar, A. K., Mismetti, P., Schellong, S., Eriksson, H., Baanstra, D., Schnee, J., & Goldhaber, S. Z. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906598 · Cited by 2,583
Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., & Palareti, G. (2008) · Chest · doi:10.1378/chest.08-0670 · Cited by 2,118
Self-citation(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
Rosendaal, F. R., Cannegieter, S. C., van der Meer, F. J. M., & Briët, E. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651587 · Cited by 2,065
Summary of product characteristics
(2013) · Pharmaceutical Medicine · doi:10.1093/med/9780199609147.003.0027 · Cited by 1,905
Petersen, P., Godtfredsen, J., Boysen, G., Andersen, E., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,820
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation: A Meta-Analysis
Hart, R. G., Benavente, O., McBride, R., & Pearce, L. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00003 · Cited by 1,638
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809329 · Cited by 1,577
(1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232201 · Cited by 1,530
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
Eriksson, B. I., Borris, L. C., Friedman, R. J., Haas, S., Huisman, M. V., Kakkar, A. K., Bandel, T. J., Beckmann, H., Muehlhofer, E., Misselwitz, F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800374 · Cited by 1,433
Effect of VKORC1 Haplotypes on Transcriptional Regulation and Warfarin Dose
Rieder, M. J., Reiner, A. P., Gage, B. F., Nickerson, D. A., Eby, C. S., McLeod, H. L., Blough, D. K., Thummel, K. E., Veenstra, D. L., & Rettie, A. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044503 · Cited by 1,399
Stangier, J., Haertter, S., Liesenfeld, K.-H., Wienen, W., Feuring, M., Clemens, A., & Ryn, J. V. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-11-0758 · Cited by 1,382
Palareti, G., Leali, N., Coccheri, S., Poggi, M., Manotti, C., D'Angelo, A., Pengo, V., Erba, N., Moia, M., Ciavarella, N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01109-9 · Cited by 1,333
Self-citationRivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
Lassen, M. R., Ageno, W., Borris, L. C., Lieberman, J. R., Rosencher, N., Bandel, T. J., Misselwitz, F., & Turpie, A. G. G. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa076016 · Cited by 1,295
Self-citationEffect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
Hylek, E. M., Go, A. S., Chang, Y., Jensvold, N. G., Henault, L. E., Selby, J. V., & Singer, D. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022913 · Cited by 1,277
Self-citationOsteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone
Hauschka, P. V., Lian, J. B., Cole, D. E., & Gundberg, C. M. (1989) · Physiological Reviews · doi:10.1152/physrev.1989.69.3.990 · Cited by 1,272
Evidence-Based Management of Anticoagulant Therapy
Holbrook, A., Schulman, S., Witt, D. M., Vandvik, P. O., Fish, J., Kovacs, M. J., Svensson, P. J., Veenstra, D. L., Crowther, M., & Guyatt, G. H. (2012) · Chest · doi:10.1378/chest.11-2295 · Cited by 1,269
Self-citationAithal, G. P., Day, C. P., Kesteven, P. J., & Daly, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)04474-2 · Cited by 1,243
Low-Dose Aspirin for the Prevention of Atherothrombosis
Patrono, C., García Rodríguez, L. A., Landolfi, R., & Baigent, C. (2005) · New England Journal of Medicine · doi:10.1056/nejmra052717 · Cited by 1,218
Systematic overview of warfarin and its drug and food interactions
Holbrook, A. M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1095 · Cited by 1,160
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
Ezekowitz, M. D., Bridgers, S. L., James, K. E., Carliner, N. H., Colling, C. L., Gornick, C. C., Krause-Steinrauf, H., Kurtzke, J. F., Nazarian, S. M., Radford, M. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272002 · Cited by 1,160
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
Rost, S., Fregin, A., Ivaskevicius, V., Conzelmann, E., Hörtnagel, K., Pelz, H.-J., Lappegard, K., Seifried, E., Scharrer, I., Tuddenham, E. G. D., et al. (2004) · Nature · doi:10.1038/nature02214 · Cited by 1,134
Weitz, J. I., Hudoba, M., Massel, D., Maraganore, J., & Hirsh, J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114723 · Cited by 1,123
Eriksson, B. I., Dahl, O. E., Rosencher, N., Kurth, A. A., van Dijk, C. N., Frostick, S. P., Prins, M. H., Hettiarachchi, R., Hantel, S., Schnee, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61445-7 · Cited by 1,116
Canadian atrial fibrillation anticoaguiation (CAFA) study
Connolly, S. J., Laupacis, A., Gent, M., Roberts, R. S., Cairns, J. A., & Joyner, C. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90585-w · Cited by 1,111
Kakkar, A. K., Brenner, B., Dahl, O. E., Eriksson, B. I., Mouret, P., Muntz, J., Soglian, A. G., Pap, Á. F., Misselwitz, F., & Haas, S. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60880-6 · Cited by 1,070
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280227 · Cited by 1,067
Higashi, M. K. (2002) · JAMA · doi:10.1001/jama.287.13.1690 · Cited by 1,048
Gage, B. F., Yan, Y., Milligan, P. E., Waterman, A. D., Culverhouse, R., Rich, M. W., & Radford, M. J. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.017 · Cited by 1,008
Maternal and fetal sequelae of anticoagulation during pregnancy
Hall, J. G., Pauli, R. M., & Wilson, K. M. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90181-3 · Cited by 997
Turpie, A. G., Lassen, M. R., Davidson, B. L., Bauer, K. A., Gent, M., Kwong, L. M., Cushner, F. D., Lotke, P. A., Berkowitz, S. D., Bandel, T. J., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60734-0 · Cited by 981
ERIKSSON, B. I., DAHL, O. E., ROSENCHER, N., KURTH, A. A., VAN DIJK, C. N., FROSTICK, S. P., KÄLEBO, P., CHRISTIANSEN, A. V., HANTEL, S., HETTIARACHCHI, R., et al. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02748.x · Cited by 979
Sconce, E. A., Khan, T. I., Wynne, H. A., Avery, P., Monkhouse, L., King, B. P., Wood, P., Kesteven, P., Daly, A. K., & Kamali, F. (2005) · Blood · doi:10.1182/blood-2005-03-1108 · Cited by 947
Lipowski, Z. J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92478-7 · Cited by 944
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin
Hylek, E. M., & Singer, D. E. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-11-199406010-00001 · Cited by 919
Self-citationOptimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves
Cannegieter, S. C., Rosendaal, F. R., Wintzen, A. R., van der Meer, F. J. M., Vandenbroucke, J. P., & Briet, E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507063330103 · Cited by 908
Stangier, J., Rathgen, K., Stähle, H., Gansser, D., & Roth, W. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02899.x · Cited by 887
Connolly, S. J., Pogue, J., Eikelboom, J., Flaker, G., Commerford, P., Franzosi, M. G., Healey, J. S., & Yusuf, S. (2008) · Circulation · doi:10.1161/circulationaha.107.750000 · Cited by 870
Roth, G. J., & Majerus, P. W. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108132 · Cited by 861
Hansen, M. L., Sørensen, R., Clausen, M. T., Fog-Petersen, M. L., Raunsø, J., Gadsbøll, N., Gislason, G. H., Folke, F., Andersen, S. S., Schramm, T. K., et al. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.271 · Cited by 855
Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
Gage, B., Eby, C., Johnson, J., Deych, E., Rieder, M., Ridker, P., Milligan, P., Grice, G., Lenzini, P., Rettie, A., et al. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.10 · Cited by 847
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism
Miners, J. O., & Birkett, D. J. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00721.x · Cited by 844
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
Ridker, P. M., Goldhaber, S. Z., Danielson, E., Rosenberg, Y., Eby, C. S., Deitcher, S. R., Cushman, M., Moll, S., Kessler, C. M., Elliott, C. G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035029 · Cited by 808
Hylek, E. M., Skates, S. J., Sheehan, M. A., & Singer, D. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608223350802 · Cited by 789
Self-citationBeyth, R. J., Quinn, L. M., & Landefeld, C. S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00198-3 · Cited by 773
Kearon, C., Ginsberg, J. S., Kovacs, M. J., Anderson, D. R., Wells, P., Julian, J. A., MacKinnon, B., Weitz, J. I., Crowther, M. A., Dolan, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035422 · Cited by 751
Self-citationAntithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · Chest · doi:10.1378/chest.08-0678 · Cited by 751
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
Schulman, S., Beyth, R. J., Kearon, C., & Levine, M. N. (2008) · Chest · doi:10.1378/chest.08-0674 · Cited by 740
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis
Hull, R., Hirsh, J., Jay, R., Carter, C., England, C., Gent, M., Turpie, A. G. G., McLoughlin, D., Dodd, P., Thomas, M., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212303072704 · Cited by 728
Anderson, J. L., Horne, B. D., Stevens, S. M., Grove, A. S., Barton, S., Nicholas, Z. P., Kahn, S. F. S., May, H. T., Samuelson, K. M., Muhlestein, J. B., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.737312 · Cited by 727
Stangier, J., Rathgen, K., Stähle, H., & Mazur, D. (2010) · Clinical Pharmacokinetics · doi:10.2165/11318170-000000000-00000 · Cited by 722
Identification of the gene for vitamin K epoxide reductase
Li, T., Chang, C.-Y., Jin, D.-Y., Lin, P.-J., Khvorova, A., & Stafford, D. W. (2004) · Nature · doi:10.1038/nature02254 · Cited by 707
D'Andrea, G., D'Ambrosio, R. L., Di Perna, P., Chetta, M., Santacroce, R., Brancaccio, V., Grandone, E., & Margaglione, M. (2005) · Blood · doi:10.1182/blood-2004-06-2111 · Cited by 699
Drug Interactions with Tobacco Smoking: An Update
Zevin, S., & Benowitz, N. L. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936060-00004 · Cited by 692
The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans
Blech, S., Ebner, T., Ludwig-Schwellinger, E., Stangier, J., & Roth, W. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.019083 · Cited by 689
Risk Factors for Complications of Chronic Anticoagulation: A Multicenter Study
Fihn, S. D., McDonell, M., Martin, D., Henikoff, J., Vermes, D., Kent, D., White, R. H., & for the Warfarin Optimized Outpatient Follow-up Study Group* (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00005 · Cited by 671
Stangier, J. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847050-00001 · Cited by 655
KUBITZA, D., BECKA, M., VOITH, B., ZUEHLSDORF, M., & WENSING, G. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.06.011 · Cited by 649
Kubitza, D., Becka, M., Wensing, G., Voith, B., & Zuehlsdorf, M. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0043-5 · Cited by 640
(2009) · The Journal of Arthroplasty · doi:10.1016/j.arth.2008.01.132 · Cited by 631
Chiquette, E., Amato, M. G., & Bussey, H. I. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.15.1641 · Cited by 596
PERZBORN, E., STRASSBURGER, J., WILMEN, A., POHLMANN, J., ROEHRIG, S., SCHLEMMER, K.-H., & STRAUB, A. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01166.x · Cited by 590
White, H. D. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.3.239 · Cited by 575
The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin
Fihn, S. D., Callahan, C. M., Martin, D. C., McDonell, M. B., Henikoff, J. G., White, R. H., & National Consortium of Anticoagulation Clinics* (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-11-199606010-00004 · Cited by 555
A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement
Turpie, A., Gent, M., Laupacis, A., Latour, Y., Gunstensen, J., Basile, F., Klimek, M., & Hirsh, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290802 · Cited by 547
(1997) · ACC Current Journal Review · doi:10.1016/s1062-1458(97)83303-x · Cited by 539
Bleeding complications in oral anticoagulant therapy. An analysis of risk factors
van der Meer, F. J. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.13.1557 · Cited by 538
The Mode of Action of Vitamin K
Nelsestuen, G. L., Zytkovicz, T. H., & Howard, J. B. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42259-x · Cited by 528
Effect of Study Setting on Anticoagulation Control
van Walraven, C., Jennings, A., Oake, N., Fergusson, D., & Forster, A. J. (2006) · Chest · doi:10.1378/chest.129.5.1155 · Cited by 487
(1997) · Annals of Neurology · doi:10.1002/ana.410420606 · Cited by 480
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
Hauel, N. H., Nar, H., Priepke, H., Ries, U., Stassen, J.-M., & Wienen, W. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0109513 · Cited by 457
Assessment of laboratory assays to measure rivaroxaban – an oral, direct factor Xa inhibitor
Martinoli, J.-L., LeFlem, L., Guinet, C., Plu-Bureau, G., Depasse, F., Perzborn, E., & Samama, M. M. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-03-0176 · Cited by 449
Self-monitoring of oral anticoagulation: a systematic review and meta-analysis
Heneghan, C., Alonso-Coello, P., Garcia-Alamino, J., Perera, R., Meats, E., & Glasziou, P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68139-7 · Cited by 438
Bleeding Complications in Oral Anticoagulant Therapy: An Analysis of Risk Factors
van der Meer, F. J. M. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410130073007 · Cited by 433
Stangier, J., Stähle, H., Rathgen, K., & Fuhr, R. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847010-00005 · Cited by 427
(1995) · New England Journal of Medicine · doi:10.1056/nejm199507063330102 · Cited by 425
Ezekowitz, M. D., Reilly, P. A., Nehmiz, G., Simmers, T. A., Nagarakanti, R., Parcham-Azad, K., Pedersen, K. E., Lionetti, D. A., Stangier, J., & Wallentin, L. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.034 · Cited by 419
STAFFORD, D. W. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01419.x · Cited by 402
Dahl, O., Huo, M., Kurth, A., Hantel, S., Hermansson, K., Schnee, J., Friedman, R., Eriksson, B., & for the RE-NOVATE II Study Group (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-10-0679 · Cited by 401
Pharmacokinetic and Pharmacodynamic Properties of Oral Anticoagulants, Especially Phenprocoumon
Haustein, K.-O. (1999) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-996417 · Cited by 387
Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition
Whitlon, D. S., Sadowski, J. A., & Suttie, J. W. (1978) · Biochemistry · doi:10.1021/bi00601a003 · Cited by 384
Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation
Hylek, E. M. (1998) · JAMA · doi:10.1001/jama.279.9.657 · Cited by 378
Self-citationTrial of Different Intensities of Anticoagulation in Patients with Prosthetic Heart Valves
Saour, J. N., Sieck, J. O., Mamo, L. A. R., & Gallus, A. S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002153220703 · Cited by 368
Self-citationCaraco, Y., Blotnick, S., & Muszkat, M. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100316 · Cited by 360
Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy
Harrison, L., Johnston, M., Massicotte, M. P., Crowther, M., Moffat, K., & Hirsh, J. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-2-199701150-00006 · Cited by 359
Self-citationLeissinger, C. A., Blatt, P. M., Hoots, W. K., & Ewenstein, B. (2008) · American Journal of Hematology · doi:10.1002/ajh.21046 · Cited by 353
Risk of Thromboembolism With Short-term Interruption of Warfarin Therapy
Garcia, D. A. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.23 · Cited by 353
Witt, D. M., Sadler, M. A., Shanahan, R. L., Mazzoli, G., & Tillman, D. J. (2005) · Chest · doi:10.1378/chest.127.5.1515 · Cited by 348
Scordo, M. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.129321 · Cited by 344
Kubitza, D., Becka, M., Zuehlsdorf, M., & Mueck, W. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006296058 · Cited by 334
Couban, S., Goodyear, M., Burnell, M., Dolan, S., Wasi, P., Barnes, D., MacLeod, D., Burton, E., Andreou, P., & Anderson, D. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.192 · Cited by 331
Hemorrhagic Complications of Anticoagulant Therapy
Coon, W. W. (1974) · Archives of Internal Medicine · doi:10.1001/archinte.133.3.386 · Cited by 316
Turpie, A. G. G., Hirsh, J., Gunstensen, J., Nelson, H., & Gent, M. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92070-3 · Cited by 315
Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis
Anand, S. S. (1999) · JAMA · doi:10.1001/jama.282.21.2058 · Cited by 311
Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction
(1997) · The Lancet · doi:10.1016/s0140-6736(97)01180-x · Cited by 301
Gulløv, A. L., Koefoed, B. G., Petersen, P., Pedersen, T. S., Andersen, E. D., Godtfredsen, J., & Boysen, G. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.14.1513 · Cited by 301
Calibration of Reference Thromboplastins and Standardisation of the Prothrombin Time Ratio
Kirkwood, T. B. L. (1983) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657371 · Cited by 300
Chesebro, J. H., Fuster, V., Elveback, L. R., McGoon, D. C., Pluth, J. R., Puga, F. J., Wallace, R. B., Danielson, G. K., Orszulak, T. A., Piehler, J. M., et al. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90673-2 · Cited by 300
Stangier, J., Eriksson, B. I., Dahl, O. E., Ahnfelt, L., Nehmiz, G., Stähle, H., Rathgen, K., & Svärd, R. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005274550 · Cited by 296
Kimmel, S. E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.3.229 · Cited by 290
Andreotti, F., Testa, L., Biondi-Zoccai, G. G. L., & Crea, F. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi485 · Cited by 289
Marchetti, S., Mazzanti, R., Beijnen, J. H., & Schellens, J. H. M. (2007) · The Oncologist · doi:10.1634/theoncologist.12-8-927 · Cited by 284
Bleeding During Antithrombotic Therapy in Patients With Atrial Fibrillation
(1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440040081009 · Cited by 283
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
Izzo, A. A., Di Carlo, G., Borrelli, F., & Ernst, E. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.06.039 · Cited by 278
Gitter, M. J., Jaeger, T. M., Petterson, T. M., Gersh, B. J., & Silverstein, M. D. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.8.725 · Cited by 276
Rivaroxaban: A New Oral Factor Xa Inhibitor
Perzborn, E., Roehrig, S., Straub, A., Kubitza, D., Mueck, W., & Laux, V. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.202978 · Cited by 276
Borris, L. C., Dahl, O. E., Haas, S., Huisman, M. V., Kakkar, A. K., Kälebo, P., Muelhofer, E., Misselwitz, F., Eriksson, B. I., & Mueck, W. (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-12-0714 · Cited by 273
Lassen, M. R., Eriksson, B., Gent, M., Berkowitz, S., Misselwitz, F., Bandel, T., Homering, M., Westermeier, T., Kakkar, A., & Turpie, A. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-09-0601 · Cited by 269
Kubitza, D., Becka, M., Roth, A., & Mueck, W. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802361499 · Cited by 268
Age as a determinant of sensitivity to warfarin.
Shepherd, A., Hewick, D., Moreland, T., & Stevenson, I. (1977) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1977.tb00719.x · Cited by 262
Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man
Breckenridge, A., Orme, M., Wesseling, H., Lewis, R. J., & Gibbons, R. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974154424 · Cited by 261
Interindividual variability in sensitivity to warfarin-Nature or nurture?
Loebstein, R. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117444 · Cited by 260
Geisen, C., Watzka, M., Sittinger, K., Steffens, M., Daugela, L., Seifried, E., Müller, C. R., Wienker, T. F., & Oldenburg, J. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-04-0290 · Cited by 259
Kubitza, D., Becka, M., Zuehlsdorf, M., & Mueck, W. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006286904 · Cited by 254
Stassen, J.-M., Priepke, H., Ries, U. J., Hauel, N., & Wienen, W. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-03-0183 · Cited by 250
Vitamin K-dependent Proteins, Warfarin, and Vascular Calcification
Danziger, J. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00770208 · Cited by 250
Fang, M. C., Go, A. S., Hylek, E. M., Chang, Y., Henault, L. E., Jensvold, N. G., & Singer, D. E. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00828.x · Cited by 249
Self-citationMueck, W., Eriksson, B. I., Bauer, K. A., Borris, L., Dahl, O. E., Fisher, W. D., Gent, M., Haas, S., Huisman, M. V., Kakkar, A. K., et al. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847030-00006 · Cited by 243
Warfarin Maintenance Dosing Patterns in Clinical Practice
Garcia, D., Regan, S., Crowther, M., Hughes, R. A., & Hylek, E. M. (2005) · Chest · doi:10.1378/chest.127.6.2049 · Cited by 241
Self-citationYuan, C.-S., Wei, G., Dey, L., Karrison, T., Nahlik, L., Maleckar, S., Kasza, K., Ang-Lee, M., & Moss, J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-1-200407060-00011 · Cited by 240
Aging and the Anticoagulant Response to Warfarin Therapy
Gurwitz, J. H., Avorn, J., Ross-Degnan, D., Choodnovskiy, I., & Ansell, J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-11-901 · Cited by 231
Lubetsky, A., Yonath, H., Olchovsky, D., Loebstein, R., Halkin, H., & Ezra, D. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.20.2469 · Cited by 227
Kovacs, M. J., Rodger, M., Anderson, D. R., Morrow, B., Kells, G., Kovacs, J., Boyle, E., & Wells, P. S. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-9-200305060-00007 · Cited by 223
Multicentre randomised study of computerised anticoagulant dosage
Poller, L., Shiach, C., MacCallum, P., Johansen, A., Münster, A., Magalhäes, A., & Jespersen, J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04147-6 · Cited by 222
Schmitt, L., Speckman, J., & Ansell, J. (2003) · Journal of Thrombosis and Thrombolysis · doi:10.1023/b:thro.0000011377.78585.63 · Cited by 221
Influence of CYP2C9 genotype on warfarin dose requirements—a systematic review and meta-analysis
Lindh, J. D., Holm, L., Andersson, M. L., & Rane, A. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0584-5 · Cited by 218
Studies on the optical enantiomorphs of warfarin in man
Reilly, R. A. O. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974162348 · Cited by 213
Landefeld, C. S., Rosenblatt, M. W., & Goldman, L. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90565-2 · Cited by 211
The Stereoselective Interaction of Warfarin and Metronidazole in Man
O'Reilly, R. A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608122950702 · Cited by 209
Veeger, N. J. G. M., Piersma‐Wichers, M., Tijssen, J. G. P., Hillege, H. L., & van der Meer, J. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05348.x · Cited by 207
Dentali, F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.2.117 · Cited by 206
Congenital malformations associated with the administration of oral anticoagulants during pregnancy
Lietman, P. S., Pettifor, J. M., & Benson, R. (1975) · The Journal of Pediatrics · doi:10.1016/s0022-3476(75)80986-3 · Cited by 204
Interaction of Warfarin With Drugs, Natural Substances, and Foods
Greenblatt, D. J., & von Moltke, L. L. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004271404 · Cited by 199
A Randomized Trial Comparing 5-mg and 10-mg Warfarin Loading Doses
Crowther, M. A., Ginsberg, J. B., Kearon, C., Harrison, L., Johnson, J., Massicotte, M. P., & Hirsh, J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.1.46 · Cited by 199
Self-citationProtein C and the Development of Skin Necrosis During Anticoagulant Therapy
Broekmans, A. W., Bertina, R. M., Loeliger, E. A., Hofmann, V, & Klingemann, H.-G. (1983) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657378 · Cited by 199
Wilson, J.-A. S., Wells, P. S., Kovacs, M. J., Lewis, G. M., Martin, J. E., Burton, E., & Anderson, D. R. (2003) · Europe PMC (PubMed Central) · Cited by 197
Tripodi, A., Chantarangkul, V., Primignani, M., Fabris, F., Dell'Era, A., Sei, C., & Mannuccio Mannucci, P. (2007) · Hepatology · doi:10.1002/hep.21732 · Cited by 196
Hillman, M. A., Wilke, R. A., Yale, S. H., Vidaillet, H. J., Caldwell, M. D., Glurich, I., Berg, R. L., Schmelzer, J., & Burmester, J. K. (2005) · Clinical Medicine & Research · doi:10.3121/cmr.3.3.137 · Cited by 196
Role of Vitamin-K-Dependent Proteins in Bone Metabolism
Price, P. A. (1988) · Annual Review of Nutrition · doi:10.1146/annurev.nu.08.070188.003025 · Cited by 196
Studies on Coumarin Anticoagulant Drugs: Initiation of Warfarin Therapy Without a Loading Dose
O'REILLY, R. A., & AGGELER, P. M. (1968) · Circulation · doi:10.1161/01.cir.38.1.169 · Cited by 192
Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype
Voora, D., Eby, C., Linder, M. W., Milligan, P. E., Bukaveckas, B. L., McLeod, H. L., Maloney, W., Clohisy, J., Burnett, S. R., Grosso, L., et al. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-08-0542 · Cited by 189
Crowther, M. A., Clase, C. M., Margetts, P. J., Julian, J., Lambert, K., Sneath, D., Nagai, R., Wilson, S., & Ingram, A. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000027356.16598.99 · Cited by 186
Self-citationFlaker, G. C., Gruber, M., Connolly, S. J., Goldman, S., Chaparro, S., Vahanian, A., Halinen, M. O., Horrow, J., & Halperin, J. L. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.06.024 · Cited by 181
Stangier, J., Stähle, H., Rathgen, K., Roth, W., & Shakeri‐Nejad, K. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008324179 · Cited by 177
Factors affecting the maintenance dose of warfarin.
James, A. H., Britt, R. P., Raskino, C. L., & Thompson, S. G. (1992) · Journal of Clinical Pathology · doi:10.1136/jcp.45.8.704 · Cited by 176
Jiang, X., Williams, K. M., Liauw, W. S., Ammit, A. J., Roufogalis, B. D., Duke, C. C., Day, R. O., & McLachlan, A. J. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02322.x · Cited by 172
LAUNBJERG, J., EGEBLAD, H., HEAF, J., NIELSEN, N. H., FUGLEHOLM, A. M., & LADEFOGED, K. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00358.x · Cited by 169
Schulze, H., & Shivdasani, R. A. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01426.x · Cited by 168
Drug-Induced Liver Injury in Humans: The Case of Ximelagatran
Keisu, M., & Andersson, T. B. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_13 · Cited by 163
Battistella, M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.2.189 · Cited by 162
Limdi, N. A., Arnett, D. K., Goldstein, J. A., Beasley, T. M., McGwin, G., Adler, B. K., & Acton, R. T. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.5.511 · Cited by 161
O'Donnell, M., Oczkowski, W., Fang, J., Kearon, C., Silva, J., Bradley, C., Guyatt, G., Gould, L., D'Uva, C., Kapral, M., et al. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70536-1 · Cited by 161
Ansell, J., Hollowell, J., Pengo, V., Martinez-Brotons, F., Caro, J., & Drouet, L. (2007) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-006-9022-7 · Cited by 159
GEROTZIAFAS, G. T., ELALAMY, I., DEPASSE, F., PERZBORN, E., & SAMAMA, M. M. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02429.x · Cited by 159
Warfarin and its interactions with foods, herbs and other dietary supplements
Nutescu, E. A., Shapiro, N. L., Ibrahim, S., & West, P. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.3.433 · Cited by 159
Coagulation Abnormalities in Liver Disease
Mammen, E. F. (1992) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30273-9 · Cited by 158
Kubitza, D., Becka, M., Mueck, W., & Zuehlsdorf, M. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02776.x · Cited by 158
Effect of 3.2%vs3.8% Sodium Citrate Concentration on Routine Coagulation Testing
Adcock, D. M., Kressin, D. C., & Marlar, R. A. (1997) · American Journal of Clinical Pathology · doi:10.1093/ajcp/107.1.105 · Cited by 155
Combining Antiplatelet and Anticoagulant Therapies
Holmes, D. R., Kereiakes, D. J., Kleiman, N. S., Moliterno, D. J., Patti, G., & Grines, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.044 · Cited by 155
Tweedle, D. E. F. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92190-5 · Cited by 155
Petitti, D. B., Strom, B. L., & Melmon, K. L. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90260-3 · Cited by 154
Thromboembolic and Bleeding Complications Following St. Jude Medical Valve Replacement
Hering, D., Piper, C., Bergemann, R., Hillenbach, C., Dahm, M., Huth, C., & Horstkotte, D. (2005) · CHEST Journal · doi:10.1378/chest.127.1.53 · Cited by 153
Ansell, J., & Hughes, R. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90040-x · Cited by 151
Schurgers, L. J., Shearer, M. J., Hamulyák, K., Stöcklin, E., & Vermeer, C. (2004) · Blood · doi:10.1182/blood-2004-04-1525 · Cited by 149
Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon
Brouwers, J. R. B. J., Schalekamp, T., Wilffert, B., et al. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-04-0116 · Cited by 145
Vitamin K deficiency from dietary vitamin K restriction in humans
Suttie, J., Mummah-Schendel, L. L., Shah, D. V., Lyle, B., & Greger, J. (1988) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/47.3.475 · Cited by 144
The warfarin-sulfinpyrazone interaction: stereochemical considerations
Toon, S., Low, L. K., Gibaldi, M., Trager, W. F., O’Reilly, R. A., Motley, C. H., & Goulart, D. A. (1986) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1986.3 · Cited by 144
Matchar, D. B., Samsa, G. P., Cohen, S. J., Oddone, E. Z., & Jurgelski, A. E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01131-2 · Cited by 141
Oral Anticoagulation Treatment in the Elderly
Palareti, G., Hirsh, J., Legnani, C., Manotti, C., D’Angelo, A., Pengo, V., Moia, M., Guazzaloca, G., Musolesi, S., & COCCHERI, S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.470 · Cited by 140
Self-citationGraff, J., von Hentig, N., Misselwitz, F., Kubitza, D., Becka, M., Breddin, H., & Harder, S. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007302952 · Cited by 139
Maillard, C., Berruyer, M., Serre, C., DECHAVANNE, M., & Delmas, P. D. (1992) · Endocrinology · doi:10.1210/endo.130.3.1531628 · Cited by 139
Flier, J. S., Underhill, L. H., Wessler, S., & Gitel, S. N. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409063111007 · Cited by 138
Ansell, J., Jacobson, A. K., Levy, J., Völler, H., & Hasenkam, J. M. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.11.008 · Cited by 135
Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview
Ziakas, P. D., Poulou, L. S., Rokas, G., Bartzoudis, D., & Voulgarelis, M. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02379.x · Cited by 133
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
Witt, D. M., Delate, T., Clark, N. P., Martell, C., Tran, T. S., Crowther, M. A., Garcia, D. A., Ageno, W., & Hylek, E. M. (2009) · Blood · doi:10.1182/blood-2009-02-207928 · Cited by 132
Self-citationBellest, L., Eschwège, V., Poupon, R. Y., Chazouillères, O., & Robert, A. (2007) · Hepatology · doi:10.1002/hep.21680 · Cited by 131
The kinetics of activation of normal and gamma-carboxyglutamic acid-deficient prothrombins.
Malhotra, O. P., Nesheim, M. E., & Mann, K. G. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89728-9 · Cited by 130
Risk factors for nonadherence to warfarin: results from the IN‐RANGE study
Platt, A. B., Localio, A. R., Brensinger, C. M., Cruess, D. G., Christie, J. D., Gross, R., Parker, C. S., Price, M., Metlay, J. P., Cohen, A. L., et al. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1556 · Cited by 129
Rubboli, A., Halperin, J. L., Airaksinen, J. K. E., Buerke, M., Eeckhout, É., Freedman, S. B., Gershlick, A., Schlitt, A., Tse, H., Verheugt, F. W. A., et al. (2008) · Annals of Medicine · doi:10.1080/07853890802089786 · Cited by 127
Raj, G., Kumar, R., & McKinney, W. P. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.22.2721 · Cited by 127
Oral Anticoagulation and Hemorrhagic Complications in an Elderly Population With Atrial Fibrillation
Copland, M., Walker, I. D., & Tait, R. C. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.17.2125 · Cited by 125
Sconce, E. A., Khan, T. I., Mason, J. B., Noble, F., Wynne, H., & Kamali, F. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-12-0773 · Cited by 124
Harrington, D. J., Underwood, S., Morse, C., Shearer, M. J., Tuddenham, E. G. D., & Mumford, A. D. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-08-0540 · Cited by 121
Poller, L., Keown, M., Ibrahim, S. A., Lowe, G. D. O., Moia, M., Turpie, A. G. G., Roberts, C., van den Besselaar, A. M. H. P., van der Meer, F. J. M., Tripodi, A., et al. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02959.x · Cited by 120
Self-citationSegal, J. B., McNamara, R. L., Miller, M. R., Kim, N., Goodman, S. N., Powe, N. R., Robinson, K. A., & Bass, E. B. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.04329.x · Cited by 120
Prospective comparative study of computer programs used for management of warfarin.
Poller, L., Wright, D., & Rowlands, M. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.4.299 · Cited by 118
Wolf, A. T., Wasan, S. K., & Saltzman, J. R. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00969.x · Cited by 117
Palareti, G., Manotti, C., D’Angelo, A., Pengo, V., Erba, N., Moia, M., CIAVARELLA, N., Devoto, G., Berrettini, M., Leali, N., et al. (1997) · PubMed · Cited by 115
Self-citationReduced Bone Density in Children on Long-Term Warfarin
Barnes, C. D., Newall, F. H., Ignjatović, V., Wong, P., Cameron, F. J., Jones, G., & Monagle, P. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000155943.07244.04 · Cited by 115
Warfarin dosing and cytochrome P450 2C9 polymorphisms
Johnson, F. B., Longtine, J. A., Kucher, N., Joffe, H. V., Xu, R., & Goldhaber, S. Z. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-02-0083 · Cited by 112
Pengo, V., Zasso, A., Barbero, F., Banzato, A., Nante, G., Parissenti, L., John, N., Noventa, F., & Volta, S. D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00357-9 · Cited by 109
Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans
O’Reilly, R. A., Trager, W. F., Rettie, A. E., & Goulart, D. A. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.149 · Cited by 108
O’Reilly, R. A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001033020106 · Cited by 108
Cited by
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Dabigatran versus warfarin in patients with mechanical heart valves
Eikelboom, J. W., Connolly, S. J., Brueckmann, M., Granger, C. B., Kappetein, A. P., Mack, M. J., Blatchford, J., Devenny, K., Friedman, J., Guiver, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300615 · Cited by 1,506
Evidence-Based Management of Anticoagulant Therapy
Holbrook, A., Schulman, S., Witt, D. M., Vandvik, P. O., Fish, J., Kovacs, M. J., Svensson, P. J., Veenstra, D. L., Crowther, M., & Guyatt, G. H. (2012) · Chest · doi:10.1378/chest.11-2295 · Cited by 1,269
Self-citation
Metadata
- Authors
- Ageno, W., Gallus, A. S., Wittkowsky, A., Crowther, M., Hylek, E. M., & Palareti, G.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 141
- Issue
- 2
- Pages
- e44S-e88S
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W1998354077
- Cited by
- 1,503
- References
- 291
- FWCI
- 107.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.